Subscribe
T. Schneider / Shutterstock.com
20 October 2025NewsAmericasLiz Hockley

Mitsubishi Tanabe doubles down on Radicava protection

The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Mitsubishi Tanabe takes on Indian generic drugmaker’s ALS application
2 January 2025   The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug.


Editor's picks

Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025

Editor's picks

Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
1 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

More features

‘All it takes is a post on Truth Social’: Is this patent reform's moment?
Novartis fails to block repackaged imports of blockbuster treatment
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
Top pharma, biotech, and medtech experts to gather at LSPN Fall
Protect early, partner wisely: In-house tips for medtech startups
Latham scoops Simmons partner for its London office
Data in the age of AI and why its value lies in quality, not quantity
Simmons loses another senior with litigator’s German move